China's Sinovac COVID-19 vaccine, which had been suspended due to a study subject's death that was registered in Sao Paulo as a suicide.Brazilian medical institute Butantan said in a statement it would restart trials later on Wednesday.Brazil's president, Jair Bolsonaro, a longtime China critic who has baselessly dismissed the Sinovac vaccine as lacking in credibility, had hailed Monday's suspension as a personal victory.Bolsonaro reiterated, however, on Wednesday evening that his government would purchase whatever vaccine is approved by Anvisa and the Health Ministry, which could ultimately include the Sinovac vaccine, if approved.The decision to suspend the trial - one of Sinovac's three large late-stage studies - was criticized by the.